176 related articles for article (PubMed ID: 17213190)
1. Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation.
Scarselli M; Li B; Kim SK; Wess J
J Biol Chem; 2007 Mar; 282(10):7385-96. PubMed ID: 17213190
[TBL] [Abstract][Full Text] [Related]
2. Novel structural and functional insights into M3 muscarinic receptor dimer/oligomer formation.
Hu J; Hu K; Liu T; Stern MK; Mistry R; Challiss RA; Costanzi S; Wess J
J Biol Chem; 2013 Nov; 288(48):34777-90. PubMed ID: 24133207
[TBL] [Abstract][Full Text] [Related]
3. Structural aspects of M₃ muscarinic acetylcholine receptor dimer formation and activation.
Hu J; Thor D; Zhou Y; Liu T; Wang Y; McMillin SM; Mistry R; Challiss RA; Costanzi S; Wess J
FASEB J; 2012 Feb; 26(2):604-16. PubMed ID: 22031716
[TBL] [Abstract][Full Text] [Related]
4. Rapid identification of functionally critical amino acids in a G protein-coupled receptor.
Li B; Scarselli M; Knudsen CD; Kim SK; Jacobson KA; McMillin SM; Wess J
Nat Methods; 2007 Feb; 4(2):169-74. PubMed ID: 17206152
[TBL] [Abstract][Full Text] [Related]
5. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast. Identification of point mutations that "silence" a constitutively active mutant M3 receptor and greatly impair receptor/G protein coupling.
Schmidt C; Li B; Bloodworth L; Erlenbach I; Zeng FY; Wess J
J Biol Chem; 2003 Aug; 278(32):30248-60. PubMed ID: 12750375
[TBL] [Abstract][Full Text] [Related]
6. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast: identification of second-site mutations that restore function to a coupling-deficient mutant M3 receptor.
Li B; Nowak NM; Kim SK; Jacobson KA; Bagheri A; Schmidt C; Wess J
J Biol Chem; 2005 Feb; 280(7):5664-75. PubMed ID: 15572356
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of M3 muscarinic receptor dimer/oligomer formation.
McMillin SM; Heusel M; Liu T; Costanzi S; Wess J
J Biol Chem; 2011 Aug; 286(32):28584-98. PubMed ID: 21685385
[TBL] [Abstract][Full Text] [Related]
8. Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy.
Li JH; Hamdan FF; Kim SK; Jacobson KA; Zhang X; Han SJ; Wess J
Biochemistry; 2008 Mar; 47(9):2776-88. PubMed ID: 18247581
[TBL] [Abstract][Full Text] [Related]
9. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor.
Han SJ; Hamdan FF; Kim SK; Jacobson KA; Bloodworth LM; Li B; Wess J
J Biol Chem; 2005 Oct; 280(41):34849-58. PubMed ID: 16093246
[TBL] [Abstract][Full Text] [Related]
10. Use of an in situ disulfide cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor.
Ward SD; Hamdan FF; Bloodworth LM; Siddiqui NA; Li JH; Wess J
Biochemistry; 2006 Jan; 45(3):676-85. PubMed ID: 16411743
[TBL] [Abstract][Full Text] [Related]
11. Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptor.
Han SJ; Hamdan FF; Kim SK; Jacobson KA; Brichta L; Bloodworth LM; Li JH; Wess J
J Biol Chem; 2005 Jul; 280(26):24870-9. PubMed ID: 15870064
[TBL] [Abstract][Full Text] [Related]
12. Regulation of M₃ muscarinic receptor expression and function by transmembrane protein 147.
Rosemond E; Rossi M; McMillin SM; Scarselli M; Donaldson JG; Wess J
Mol Pharmacol; 2011 Feb; 79(2):251-61. PubMed ID: 21056967
[TBL] [Abstract][Full Text] [Related]
13. Helix 8 and the i3 loop of the muscarinic M3 receptor are crucial sites for its regulation by the Gβ5-RGS7 complex.
Karpinsky-Semper D; Tayou J; Levay K; Schuchardt BJ; Bhat V; Volmar CH; Farooq A; Slepak VZ
Biochemistry; 2015 Feb; 54(4):1077-88. PubMed ID: 25551629
[TBL] [Abstract][Full Text] [Related]
14. Conserved extracellular cysteine pair in the M3 muscarinic acetylcholine receptor is essential for proper receptor cell surface localization but not for G protein coupling.
Zeng FY; Soldner A; Schöneberg T; Wess J
J Neurochem; 1999 Jun; 72(6):2404-14. PubMed ID: 10349850
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy.
Ward SD; Hamdan FF; Bloodworth LM; Wess J
J Biol Chem; 2002 Jan; 277(3):2247-57. PubMed ID: 11698401
[TBL] [Abstract][Full Text] [Related]
16. Molecular organization of the complex between the muscarinic M3 receptor and the regulator of G protein signaling, Gbeta(5)-RGS7.
Sandiford SL; Wang Q; Levay K; Buchwald P; Slepak VZ
Biochemistry; 2010 Jun; 49(24):4998-5006. PubMed ID: 20443543
[TBL] [Abstract][Full Text] [Related]
17. Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.
Hamdan FF; Ward SD; Siddiqui NA; Bloodworth LM; Wess J
Biochemistry; 2002 Jun; 41(24):7647-58. PubMed ID: 12056896
[TBL] [Abstract][Full Text] [Related]
18. CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo.
Rossi M; Ruiz de Azua I; Barella LF; Sakamoto W; Zhu L; Cui Y; Lu H; Rebholz H; Matschinsky FM; Doliba NM; Butcher AJ; Tobin AB; Wess J
Proc Natl Acad Sci U S A; 2015 Dec; 112(49):E6818-24. PubMed ID: 26598688
[TBL] [Abstract][Full Text] [Related]
19. Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor.
Tsuboi H; Nakamura Y; Iizuka M; Matsuo N; Matsumoto I; Sumida T
Mod Rheumatol; 2012 Apr; 22(2):264-71. PubMed ID: 21877253
[TBL] [Abstract][Full Text] [Related]
20. Use of a disulfide cross-linking strategy to study muscarinic receptor structure and mechanisms of activation.
Zeng FY; Hopp A; Soldner A; Wess J
J Biol Chem; 1999 Jun; 274(23):16629-40. PubMed ID: 10347230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
